Emtricitabine, Rilpivirine, Tenofovir Drug Combination MeSH Descriptor Data 2024

MeSH Heading: Emtricitabine, Rilpivirine, Tenofovir Drug Combination
Tree Number(s): D02.626.809.500; D02.705.429.906.500; D03.383.742.680.245.500.600.500; D03.383.742.755.500; D03.633.100.759.138.881.500; D26.310.407
Unique ID: D000068678
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068678
Scope Note: A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS.
Entry Term(s): Complera; Emtricitabine Rilpivirine Tenofovir Drug Combination; Emtricitabine-Rilpivirine-Tenofovir Drug Combination
Pharm Action: Antiviral Agents
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Public MeSH Note: 2016; EMTRICITABINE, RILPIVIRINE, TENOFOVIR DRUG COMBINATION was indexed under NITRILES; PYRIMIDINES; ORGANOPHOSPHONATES; ADENINE; and DEOXYCYTIDINE 2012-2015
History Note: 2016 (2012)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/31

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Organic Chemicals [D02]
- Nitriles [D02.626]
  - Rilpivirine [D02.626.809]
    - Emtricitabine, Rilpivirine, Tenofovir Drug Combination [D02.626.809.500]

Organic Chemicals [D02]
- Organophosphorus Compounds [D02.705]
  - Organophosphonates [D02.705.429]
    - Tenofovir [D02.705.429.906]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, 1-Ring [D03.383]
  - Pyrimidines [D03.383.742]
    - Pyrimidine Nucleosides [D03.383.742.680]
      - Cytidine [D03.383.742.680.245]
        
        Deoxycytidine [D03.383.742.680.245.500]
        
        Emtricitabine [D03.383.742.680.245.500.600]
        
        Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.125]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.250]
        
        Emtricitabine, Rilpivirine, Tenofovir Drug Combination [D03.383.742.680.245.500.600.500]
        
        Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.750]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, 1-Ring [D03.383]
  - Pyrimidines [D03.383.742]
    - Rilpivirine [D03.383.742.755]
      - Emtricitabine, Rilpivirine, Tenofovir Drug Combination [D03.383.742.755.500]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Fused-Ring [D03.633]
  - Heterocyclic Compounds, 2-Ring [D03.633.100]
    - Purines [D03.633.100.759]
      - Adenine [D03.633.100.759.138]
        
        Tenofovir [D03.633.100.759.138.881]
        
        Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.125]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.250]
        
        Emtricitabine, Rilpivirine, Tenofovir Drug Combination [D03.633.100.759.138.881.500]
        
        Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.750]

Pharmaceutical Preparations [D26]
- Drug Combinations [D26.310]

Emtricitabine, Rilpivirine, Tenofovir Drug Combination Preferred

Complera Narrower

page delivered in 0.168s